Adrien Procureur
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
-
- Chemotherapy-induced cardiotoxicity and mitigation
- Viral Infections and Immunology Research
Papers in
- Oncology 10
- Cancer Immunotherapy and Biomarkers 9
- CAR-T cell therapy research 2
- Cancer-related Molecular Pathways 1
-
- Cancer, Lipids, and Metabolism 1
- Co-authors
- Audrey Simonaggio (2 shared papers)Stéphane Marie. Oudard (2 shared papers)Yann Alexandre Vano (2 shared papers)Jean‐Emmanuel Bibault (1 shared paper)Lisa Belin (1 shared paper)Marie Bretagne (1 shared paper)Stéphane Éderhy (1 shared paper)Noël Zahr (2 shared papers)
- Journals
- European Heart Journal (1 paper)The Lancet Regional Health - Europe (1 paper)Future Oncology (1 paper)Cancers (1 paper)Annals of Oncology (1 paper)
- Partner nations
- FranceUnited StatesCanada
In The Last Decade
Adrien Procureur
12 papers receiving 528 citations
Adrien Procureur's Hit Papers
Peers
Comparison fields: 5 of 41
- Oncology 386
- Cardiology and Cardiovascular Medicine 107
- Immunology 60
- Neurology 29
- Radiology, Nuclear Medicine and Imaging 31
Countries citing papers authored by Adrien Procureur
This map shows the geographic impact of Adrien Procureur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrien Procureur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrien Procureur more than expected).
Fields of papers citing papers by Adrien Procureur
This network shows the impact of papers produced by Adrien Procureur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrien Procureur. The network helps show where Adrien Procureur may publish in the future.
Co-authors
The 25 scholars most cited alongside Adrien Procureur, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis Hit paper breakdown → | 2023 | 163 |
| 2 | 2023 | 114 | |
| 3 | 2022 | 64 | |
| 4 | 2023 | 61 | |
| 5 | 2021 | 55 | |
| 6 | Immune checkpoint inhibitor-associated myocarditis: a novel risk score Hit paper breakdown → | 2025 | 36 |
| 7 | 2024 | 23 | |
| 8 | 2025 | 19 | |
| 9 | 2020 | 7 | |
| 10 | 2024 | 4 | |
| 11 | 2025 | 2 | |
| 12 | 2021 | 1 |
About Adrien Procureur
Adrien Procureur is a scholar working on Oncology, Cancer Research, Neurology, Surgery and Immunology, having authored 12 papers that have together received 549 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), CAR-T cell therapy research (2 papers), Bladder and Urothelial Cancer Treatments (1 paper), Myasthenia Gravis and Thymoma (1 paper), Viral Infections and Immunology Research (1 paper), Immunotherapy and Immune Responses (1 paper), Cancer-related Molecular Pathways (1 paper) and Cancer, Lipids, and Metabolism (1 paper). The work is most often cited by research in Oncology (386 citations), Cardiology and Cardiovascular Medicine (107 citations), Immunology (60 citations), Neurology (29 citations) and Radiology, Nuclear Medicine and Imaging (31 citations). Adrien Procureur has collaborated with scholars based in France, United States and Canada. Frequent co-authors include Audrey Simonaggio, Stéphane Marie. Oudard, Yann Alexandre Vano, Jean‐Emmanuel Bibault, Lisa Belin, Marie Bretagne, Stéphane Éderhy, Noël Zahr, Yves F. Allenbach and Joe‐Elie Salem. Their work appears in journals such as European Heart Journal, The Lancet Regional Health - Europe, Future Oncology, Cancers and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.